Table 1.
Clinical characteristics in MVI-positive and MVI-negative patients with HCC.
| Parameters | MVI-Negative (n = 140) | MVI-Positive (n = 70) | p-Value |
|---|---|---|---|
| Age (years) * | 55 ± 11 | 54 ± 13 | 0.818 |
| Sex | >0.99 | ||
| Men | 124 (88.6) | 62 (88.6) | |
| Women | 16 (11.4) | 8 (11.4) | |
| Aspartate aminotransferase (U/L) † | 32.0 (24.2–48.0) | 33.0 (24.0–60.0) | 0.378 |
| Alanine aminotransferase (U/L) † | 33.5 (23.0–53.7) | 32.0 (20.7–51.2) | 0.682 |
| Alpha-fetoprotein | <0.001 | ||
| ≥400 µg/L | 28 (20.0) | 30 (42.9) | |
| <400 µg/L | 112 (80.0) | 40 (57.1) | |
| Tumor diameter (mm) † | 42.5 (30.0–65.0) | 57.0 (41.5–91.2) | <0.001 |
* Datum is means ± standard deviation. † Data are medians and numbers in parentheses are interquartile range. Sex and alpha-fetoprotein were compared with Pearson’s chi-squared test and expressed as numbers (percentages).